Abstract
Background
In recent years, the incidence of malignant disease in pregnancy has been increasing, but there are few large-scale surveys of malignant disease in pregnancy in Japan. The aim of this study was to survey malignant disease occurring during pregnancy in Japan.
Methods
Malignant disease in pregnancy was defined as diagnosis or treatment for malignant disease, except in situ carcinoma during pregnancy, or within 1-year postpartum. First, a primary survey questionnaire of the incidence of malignant disease in pregnancy and the number of deliveries over the course of 2014 was sent to 510 medical centers in Japan. Second, the survey questionnaires on the incidence of malignant diseases in pregnancy were collected and analyzed in detail.
Results
Of the 510 medical centers, 411 (81%) responded to the survey. There were 215,372 deliveries and 189 incidents (0.09%) of malignant disease in pregnancy. Of the 189 patients with malignancy, 157 detailed responses about the patients were received. The most frequently encountered cancer types were cervical cancer (36%), breast cancer (24%), and ovarian cancer (15%). During the 2 years after delivery, 15 patients (1 with breast cancer, 2 with ovarian cancer, 3 with hematologic malignancy, 4 with intestinal cancer, and 5 with others) died of the disease; most of them had advanced disease. In particular, 88% of the patients with intestinal cancers at diagnosis had advanced disease, and half of them died of disease.
Conclusions
In Japan, the most common malignancies in pregnancy in order of frequency are cervical cancer, breast cancer, and ovarian cancer. Early diagnosis and appropriate management of cancer during pregnancy are important for improving maternal and neonatal outcomes, because advanced diseases have a poor prognosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Smith LH, Danielsen B, Allen ME et al (2003) Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 189:1128–1135
de Haan J, Verheecke M, Van Calsteren K et al (2018) International Network on Cancer and Infertility Pregnancy (INCIP). Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol 19:337–346
Salani R, Billingsley CC, Crafton SM (2014) Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol 211:7–14
Shim MH, Mok CW, Chang KH et al (2016) Clinical characteristics and outcome of cancer diagnosed during pregnancy. Obstet Gynecol Sci 59:1–8
Van Calsteren K, Heyns L, De Smet F et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683–689
Maeda K (2014) Highly improved perinatal states in Japan. J Obstet Gynaecol Res 40:1968–1977
Yorifuji T, Naruse H, Kashima S et al (2012) Trends of preterm birth and low birth weight in Japan: a one hospital-based study. BMC Pregnancy Childbirth 12:162
Kusuda S, Fujimura M, Uchiyama A et al (2012) Trends in morbidity and mortality among very-low-birth-weight infants from 2003 to 2008 in Japan. Pediatr Res 72:531–538
Amant F, Van Calsteren K, Halaska MJ et al (2009) Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer 19(Suppl 1):S1–S12
Amant F, Halaska MJ, Fumagalli M et al (2014) Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 24:394–403
Loibl S, Han SN, von Minckwitz G et al (2012) Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol 13:887–896
Zagouri F, Dimitrakakis C, Marinopoulos S et al (2016) Cancer in pregnancy: disentangling treatment modalities. ESMO Open 4(1):e000016
Ustaalioglu BB, Gumus M, Unal A et al (2010) Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences. Int J Gynecol Cancer 20:698–703
Yagi A, Ueda Y, Egawa-Takata T et al (2017) Realistic fear of cervical cancer risk in Japan depending on birth year. Hum Vaccines Immunother 13:1700–1704
Hanley SJ, Yoshioka E, Ito Y et al (2015) HPV vaccination crisis in Japan. Lancet 385:2571
Gilmour S, Kanda M, Kusumi E et al (2013) HPV vaccination programme in Japan. Lancet 382:768
Miyagi E, Sukegawa A, Motoki Y et al (2014) Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results. J Obstet Gynaecol Res 40:1105–1113
Morice P, Uzan C, Gouy S et al (2012) Gynaecological cancers in pregnancy. Lancet 379:558–569
Rogers JE, Dasari A, Eng C (2016) The treatment of colorectal cancer during pregnancy: cytotoxic chemotherapy and targeted therapy challenges. Oncologist 21:563–570
Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5:283–291
Selig BP, Furr JR, Huey RW et al (2012) Cancer chemotherapeutic agents as human teratogens. Birth Defects Res A Clin Mol Teratol 94:626–650
Acknowledgements
This work was supported by a Grant from the Ministry of Health, Labour and Welfare of Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Kobayashi, Y., Tabata, T., Omori, M. et al. A Japanese survey of malignant disease in pregnancy. Int J Clin Oncol 24, 328–333 (2019). https://doi.org/10.1007/s10147-018-1352-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-018-1352-x